GW PHARMACEUTICALS PLC - ADS (GWPH) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2024

Type / Class
Equity / ADS
Symbol
GWPH
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$8,242 0
2024 Q2 38 $8,242 +$8,242 $216.89 1
2022 Q2 0 $0 -$24,000 0
2022 Q1 109 $24,000 +$24,000 $220.18 1
2021 Q3 0 $0 -$3,000 0
2021 Q2 30 $3,000 -$5,168,824,077 $100.00 1
2021 Q1 24,263,394 $5,262,704,969 +$653,318,695 $216.90 286
2020 Q4 24,328,806 $2,807,626,031 -$83,703,544 $115.41 258
2020 Q3 24,752,899 $2,409,565,111 -$35,376,733 $97.35 267
2020 Q2 24,906,977 $3,080,532,328 +$36,671,638 $122.72 288
2020 Q1 24,700,055 $2,164,207,829 -$24,341,218 $87.57 273
2019 Q4 24,731,194 $2,586,056,783 -$148,428,250 $104.56 301
2019 Q3 24,841,806 $2,857,462,500 -$68,289,382 $115.03 307
2019 Q2 25,233,772 $4,349,368,653 +$347,019,167 $172.39 311
2019 Q1 23,349,748 $3,935,669,170 +$16,669,767 $168.57 315
2018 Q4 23,443,247 $2,282,497,533 +$253,768,383 $97.39 262
2018 Q3 20,437,039 $3,529,629,092 -$3,890,248 $172.74 259
2018 Q2 21,021,835 $2,933,097,040 -$42,949,065 $139.54 245
2018 Q1 21,583,315 $2,430,607,780 -$173,974,070 $112.67 184
2017 Q4 22,942,535 $3,028,697,628 +$317,198,916 $132.01 199
2017 Q3 20,720,076 $2,103,064,088 +$174,649,795 $101.49 176
2017 Q2 19,008,902 $1,905,348,717 +$64,667,972 $100.25 164
2017 Q1 18,859,920 $2,280,843,376 -$70,694,859 $120.94 174
2016 Q4 19,727,399 $2,204,560,626 +$163,540,605 $111.75 159
2016 Q3 18,131,368 $2,406,399,234 +$427,995,220 $132.73 136
2016 Q2 15,033,763 $1,376,755,580 +$94,249,401 $91.57 114
2016 Q1 14,217,470 $1,025,670,608 +$62,635,909 $72.15 103
2015 Q4 13,390,634 $929,821,472 -$29,176,242 $69.44 103
2015 Q3 13,304,959 $1,215,500,228 +$42,362,657 $91.37 107
2015 Q2 13,283,459 $1,631,267,322 +$325,511,355 $122.84 102
2015 Q1 10,702,777 $975,112,037 +$239,733,258 $91.13 91
2014 Q4 8,099,575 $548,138,736 -$9,632,367 $67.68 85
2014 Q3 8,038,697 $650,353,603 -$35,799,394 $80.85 86
2014 Q2 8,240,677 $883,897,546 +$112,093,036 $107.29 86
2014 Q1 7,516,195 $446,209,889 +$219,394,937 $59.37 66